Published in Mol Vis on May 25, 2015
A Mutation in LTBP2 Causes Congenital Glaucoma in Domestic Cats (Felis catus). PLoS One (2016) 1.39
The many faces of the trabecular meshwork cell. Exp Eye Res (2016) 0.80
Isoforms of TGF-β in the aqueous humor of patients with pseudoexfoliation syndrome and a possible association with the long-term stability of the capsular bag after cataract surgery. Graefes Arch Clin Exp Ophthalmol (2017) 0.77
Pro-fibrotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma. Cell Cycle (2016) 0.76
Epigenetic Mechanisms of the Aging Human Retina. J Exp Neurosci (2016) 0.76
Active transforming growth factor-β2 in the aqueous humor of posterior polymorphous corneal dystrophy patients. PLoS One (2017) 0.75
HDAC Inhibitor-Mediated Epigenetic Regulation of Glaucoma-Associated TGFβ2 in the Trabecular Meshwork. Invest Ophthalmol Vis Sci (2016) 0.75
Life under pressure: The role of ocular cribriform cells in preventing glaucoma. Exp Eye Res (2016) 0.75
Additive Intraocular Pressure-Lowering Effects of Ripasudil with Glaucoma Therapeutic Agents in Rabbits and Monkeys. J Ophthalmol (2017) 0.75
Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma. PLoS One (2017) 0.75
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00
The extracellular matrix: not just pretty fibrils. Science (2009) 8.52
Detecting and describing heterogeneity in meta-analysis. Stat Med (1998) 8.44
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol (1988) 4.34
Latent high molecular weight complex of transforming growth factor beta 1. Purification from human platelets and structural characterization. J Biol Chem (1988) 3.98
A comparison of statistical methods for meta-analysis. Stat Med (2001) 2.69
Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol (1988) 2.41
Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res (1994) 2.40
Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci (1991) 2.37
Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J (1987) 2.23
TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure. Invest Ophthalmol Vis Sci (2006) 2.02
Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci (2004) 2.00
Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol (2001) 1.77
Transforming growth factor-beta in human aqueous humor. Curr Eye Res (1990) 1.65
Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol (2001) 1.62
Transforming growth factor beta regulates the metabolism of proteoglycans in bovine cartilage organ cultures. J Biol Chem (1988) 1.53
Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res (2001) 1.39
The aqueous levels of TGF-beta2 in patients with glaucoma. Int Ophthalmol (2004) 1.34
Higher concentration of transforming growth factor-beta in aqueous humor of glaucomatous eyes and diabetic eyes. Jpn J Ophthalmol (2002) 1.32
Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp Eye Res (1993) 1.26
Bone morphogenetic protein-7 is an antagonist of transforming growth factor-beta2 in human trabecular meshwork cells. Invest Ophthalmol Vis Sci (2007) 1.26
Concentration of transforming growth factor beta2 in aqueous humor. Ophthalmic Res (2004) 1.13
Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J Immunol (1990) 1.13
Transforming growth factor-beta 1, -beta 2 and -beta 3 mRNA expression in human cornea. Curr Eye Res (1995) 1.07
Severity of optic nerve damage in eyes with POAG is correlated with changes in the trabecular meshwork. J Glaucoma (1997) 1.06
Open-angle glaucoma. Am Fam Physician (2003) 1.04
[Functions of the transforming growth factor-beta superfamily in eyes]. Nippon Ganka Gakkai Zasshi (1997) 0.99
Transforming growth factor-beta 1 induces alpha-smooth muscle-actin expression in cultured human and monkey trabecular meshwork. Exp Eye Res (1996) 0.98
Transforming growth factor-beta levels in human aqueous humor of glaucomatous, diabetic and uveitic eyes. Korean J Ophthalmol (2006) 0.98
Modulation of actin mRNAs in cultured vascular cells by matrix components and TGF-beta 1. In Vitro Cell Dev Biol (1989) 0.97
Transforming growth factor-beta up-regulates type VII collagen gene expression in normal and transformed epidermal keratinocytes in culture. Biochem Biophys Res Commun (1991) 0.94
Quantitative analysis of 'plaque material' between ciliary muscle tips in normal- and glaucomatous eyes. Exp Eye Res (1986) 0.89
Glaucomatous neurodegeneration: an eye on tumor necrosis factor-alpha. Indian J Ophthalmol (2012) 0.84
Effect of transforming growth factor-beta on collagen type VI expression in human dermal fibroblasts. FEBS Lett (1992) 0.81
Future target molecules in antiglaucoma therapy: tgf-Beta may have a role to play. Ophthalmic Res (2009) 0.80
Value and limitation of meta-analysis. Pathophysiol Haemost Thromb (2003) 0.79
Role of anterior-chamber-associated immune deviation in the pathogenesis of uveitis. Dev Ophthalmol (1992) 0.77
Why negative meta-analyses may be false? Eur Neuropsychopharmacol (2013) 0.77